Home/Filings/4/0001437749-25-030648
4//SEC Filing

Disbrow Jarrett 4

Accession 0001437749-25-030648

CIK 0001385818other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 4:15 PM ET

Size

17.1 KB

Accession

0001437749-25-030648

Insider Transaction Report

Form 4
Period: 2025-10-03
Disbrow Jarrett
Chief Business Officer
Transactions
  • Award

    Common Stock

    2025-10-03+12,50061,568 total
  • Award

    Common Stock

    2025-10-03+19,60649,068 total
Footnotes (2)
  • [F1]The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus.
  • [F2]Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.

Issuer

AYTU BIOPHARMA, INC

CIK 0001385818

Entity typeother

Related Parties

1
  • filerCIK 0001640724

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:15 PM ET
Size
17.1 KB